India’s Sun Pharma gets South Africa nod for generic semaglutide after Novo Nordisk patent expiry – Firstpost
India’s Sun Pharmaceutical Industries has received approval from South Africa’s health regulator to manufacture and sell a generic…
Novo Nordisk withstands stiff generic competition post semaglutide patent expiry in India in March, 26 brands from 13 firms launched
Danish drug major Novo Nordisk seems to be withstanding stiff competition from generic players after its global blockbuster…
Novo Nordisk’s Patent Expires, Indian Pharma Lines Up for Ozempic-Like Weight-Loss Drugs – Outlook Business
Other companies, including Divi’s Laboratories, Dr. Reddy’s Laboratories, Cipla Limited, Sun Pharmaceutical Industries, Zydus Lifesciences, Torrent Pharmaceuticals, and…